Pay in 4 interest-free payments of $7.36 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
Orforglipron Shows Positive Efficacy, Tolerability in Weight Management Kennedy Ferruggia, Associate Editor Luke Halpern, Associate Editor Key Takeaways Orforglipron, an oral GLP-1 receptor agonist, achieved significant weight loss in a 72-week trial, meeting primary and secondary endpoints
This prospective, single-arm, open-label, single-centre study was conducted in obese individuals with type 2 diabetes
Yoshimura, R., Hori, H., Katsuki, A., Atake, K
By Her Lab Worked to Future-Proof Fruits and Vegetables Erin McGuire ran a research network that studied how to get healthy food to marginalized populations around the world
US$ 22.75
)
US$ 21.60
US$ 22.95
US$ 25.22
US$ 21.98
US$ 28.84
US$ 27.52
US$ 27.12
